Amalgamated Bank Neurocrine Biosciences Inc Transaction History

Amalgamated Bank

  • $13.6 Billion
  • Q3 2025

A detailed history of Amalgamated Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Amalgamated Bank holds 47,909 shares of NBIX stock, worth $6.86 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
47,909
Previous 47,260 1.37%
Holding current value
$6.86 Million
Previous $5.94 Million 13.22%
% of portfolio
0.05%
Previous 0.05%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025
BUY
$123.98 - $146.67 $80,463 - $95,188
649 Added 1.37%
47,909 $6.73 Million
Q2 2025

Aug 04, 2025
SELL
$87.54 - $128.18 $40,180 - $58,834
-459 Reduced 0.96%
47,260 $5.94 Million
Q1 2025

Apr 25, 2025
SELL
$107.22 - $153.29 $203,181 - $290,484
-1,895 Reduced 3.82%
47,719 $5.28 Million
Q4 2024

Feb 04, 2025
SELL
$111.62 - $139.44 $102,243 - $127,727
-916 Reduced 1.81%
49,614 $6.77 Million
Q3 2024

Oct 30, 2024
SELL
$114.58 - $153.15 $176,567 - $236,004
-1,541 Reduced 2.96%
50,530 $5.82 Million
Q2 2024

Aug 12, 2024
SELL
$130.86 - $143.19 $405,404 - $443,602
-3,098 Reduced 5.62%
52,071 $7.17 Million
Q1 2024

Apr 23, 2024
SELL
$130.4 - $143.74 $1.67 Million - $1.84 Million
-12,814 Reduced 18.85%
55,169 $7.61 Million
Q4 2023

Feb 06, 2024
SELL
$106.07 - $132.76 $74,567 - $93,330
-703 Reduced 1.02%
67,983 $8.96 Million
Q3 2023

Nov 08, 2023
SELL
$94.02 - $117.1 $119,311 - $148,599
-1,269 Reduced 1.81%
68,686 $7.73 Million
Q2 2023

Aug 11, 2023
SELL
$89.53 - $104.87 $175,389 - $205,440
-1,959 Reduced 2.72%
69,955 $6.6 Million
Q1 2023

May 02, 2023
SELL
$94.11 - $123.02 $199,513 - $260,802
-2,120 Reduced 2.86%
71,914 $7.28 Million
Q4 2022

Feb 10, 2023
BUY
$106.72 - $127.06 $34,470 - $41,040
323 Added 0.44%
74,034 $8.84 Million
Q3 2022

Nov 09, 2022
BUY
$92.03 - $107.81 $192,250 - $225,215
2,089 Added 2.92%
73,711 $7.83 Million
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $72,758 - $96,067
960 Added 1.36%
71,622 $6.98 Million
Q1 2022

Jun 30, 2022
BUY
$72.45 - $94.81 $1,014 - $1,327
14 Added 0.02%
70,662 $6.63 Million
Q4 2021

Feb 15, 2022
BUY
$79.65 - $106.22 $269,933 - $359,979
3,389 Added 5.04%
70,648 $6.02 Million
Q3 2021

Oct 29, 2021
SELL
$86.18 - $99.03 $607,051 - $697,567
-7,044 Reduced 9.48%
67,259 $6.45 Million
Q2 2021

Aug 16, 2021
BUY
$89.43 - $102.27 $5.1 Million - $5.83 Million
56,987 Added 329.1%
74,303 $7.23 Million
Q1 2021

May 13, 2021
SELL
$87.57 - $119.4 $112,965 - $154,026
-1,290 Reduced 6.93%
17,316 $1.68 Million
Q4 2020

Feb 12, 2021
BUY
$86.91 - $108.33 $347 - $433
4 Added 0.02%
18,606 $1.78 Million
Q3 2020

Oct 30, 2020
SELL
$96.16 - $135.15 $45,964 - $64,601
-478 Reduced 2.51%
18,602 $1.79 Million
Q2 2020

Aug 10, 2020
SELL
$85.09 - $130.36 $408,261 - $625,467
-4,798 Reduced 20.09%
19,080 $2.33 Million
Q1 2020

May 13, 2020
SELL
$75.11 - $113.76 $28,166 - $42,660
-375 Reduced 1.55%
23,878 $2.07 Million
Q4 2019

Feb 13, 2020
BUY
$86.8 - $118.57 $127,769 - $174,535
1,472 Added 6.46%
24,253 $2.61 Million
Q3 2019

Nov 13, 2019
BUY
$83.82 - $101.5 $233,773 - $283,083
2,789 Added 13.95%
22,781 $2.05 Million
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $29,762 - $37,603
-412 Reduced 2.02%
19,992 $1.69 Million
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $31,189 - $41,188
450 Added 2.26%
20,404 $1.8 Million
Q4 2018

Feb 15, 2019
BUY
$68.32 - $124.36 $528,933 - $962,795
7,742 Added 63.4%
19,954 $1.43 Million
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $851,455 - $1.08 Million
-8,611 Reduced 41.35%
12,212 $1.5 Million
Q2 2018

Jul 18, 2018
BUY
$75.3 - $105.99 $143,898 - $202,546
1,911 Added 10.1%
20,823 $2.05 Million
Q1 2018

May 22, 2018
BUY
$75.88 - $92.43 $108,356 - $131,990
1,428 Added 8.17%
18,912 $1.57 Million
Q4 2017

Feb 13, 2018
BUY
$58.53 - $77.59 $55,427 - $73,477
947 Added 5.73%
17,484 $1.36 Million
Q3 2017

Nov 09, 2017
BUY
$47.97 - $61.28 $793,279 - $1.01 Million
16,537
16,537 $1.01 Million

Others Institutions Holding NBIX

# of Institutions
693
Shares Held
102M
Call Options Held
290K
Put Options Held
214K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email